Page 11 - CIBERBBN-2015-eng
P. 11
Significant Activities Projects
The projects under way in 2015 were as follows:
NATIONAL PROJECTS
Financing agency: Instituto de Salud Carlos III
• Miguel Servet Human Resources Contracting aid.
• STRUCTGEL. Nanostructured Gel for Cellular Therapy of Degenerative Skeletal Disorders.
Other financing agencies
• FECYT and CAIXA: Biomedicine with and for Soci- ety.
• Junta de Castilla y León regional authority: Cell therapy in the failure of the ocular surface: devel- opment of a culture medium to improve the bios- ecurity of stem cell transplants.
• Ministry of Education, Culture and Sport: 2 José
Organization
• NANGIOFRAC. Angiogenic nanostructured mate- rials for non-consolidating bone fractures.
• Role of monocytes/macrophages in the evolution of patients with acute kidney failure through car- dio-renal syndrome 1 and their relation with the integration of renal epithelium.
• Molecular links between diabetes and neurode- generative disorders.
Financing agency: Ministry of the Economy and Competitiveness
• NANOCARDIOCOCO. Nanotechnology for cardiol- ogy and pneumococcus.
• PHYTECH. Development of biomaterials coated with phytate to stimulate bone regeneration.
• 4 grants for contracting Technical Support staff.
• Ramón y Cajal aid for contracting Human Re- sources.
• PRONANBIOSIS. Consolidation of the manage- ment model and promotion of NANBIOSIS.
• ANSHEART. The autonomic nervous system as a modulator of the cardiac function: comprehen- sive research by signal processing and computa- tional modelling.
• TERARMET. Development of therapies for treat- ment of congenital metabolic rare diseases.
• TERET. New treatments for degenerative diseas- es of the retina.
• INNCIDE. PETRA UVAT CIBER-BBN.
Castillejo grants for mobility.
• Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria: Optimisation of the cow’s dry period by protein nanoparticles.
It should be stressed that CIBER-BBN coordinates one of the three CIBER interdisciplinary excellence projects financed by the AES, “Molecular links be- tween diabetes and neurodegenerative disorders”, with the aim of identifying common molecular mechanisms between diabetes and neurodegen- erative diseases. Groups from the CIBER of Neuro- degenerative Disease (CIBERNED), Rare Diseases (CIBERER) and from the CIBER of Diabetes and As- sociated Metabolic Diseases (CIBERDEM) are also taking part in the project.
INTERNATIONAL EUROPEAN COMMISSION PROJECTS
• BERENICE. Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Cha- gas disease.
• NEUROGRAPHENE. Neurological recordings with Graphene.
• DRIVE. Diabetes Reversing Implants with en- hanced Viability and long-term Efficacy Project.
• E-MEDIVIP. E-learning platform for medical infor- matics to improve vocational and ict practice.
The CIBER-BBN’s participation in the European DRIVE project should also be stressed. This project was got under way in June 2015 with the aim of developing biomaterials and new surgical devices to improve the transplant and survival of insulin- producing pancreatic islets for treating diabetes.
CIBER-BBN I Annual report 2015 I 11


































































































   9   10   11   12   13